[1] KEGGIN, J., MILES, F. Structures and Formulæ of the Prussian Blues and Related Compounds. Nature 137, 577–578 (1936).
[2] Patra CR. Prussian blue nanoparticles and their analogues for application to cancer theranostics. Nanomedicine (Lond). 2016 Mar;11(6):569-72.
[3] Busquets MA, Estelrich J. Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications. Drug Discov Today. 2020 Aug;25(8):1431-1443.
[5] Mohammad A, Faustino PJ, Khan MA, Yang Y. Long-term stability study of Prussian blue - a quality assessment of water content and thallium binding. Int J Pharm. 2014 Dec 30;477(1-2):122-7.
[6] Mohammad A, Yang Y, Khan MA, Faustino PJ. A long-term stability study of Prussian blue: A quality assessment of water content and cesium binding. J Pharm Biomed Anal. 2015 Jan 25;103:85-90.
[7] Center for Disease Control.Available online:https://emergency.cdc.gov/radiation/prussianblue.asp(accessed on 11 June 2018).
[8] Tong X, Srivatsan A, Jacobson O, Wang Y, Wang Z, Yang X, Niu G, Kiesewetter DO, Zheng H, Chen X. Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy. Sci Rep. 2016 Aug 22;6:31551.
[9] Hu X, Mei S, Meng W, Xue S, Jiang L, Yang Y, Hui L, Chen Y, Guan MX. CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance. Cancer Lett. 2018 Jul 1;425:1-12.
